期刊文献+

CDK4蛋白在口腔粘膜癌变过程中表达的研究 被引量:4

Expression of CDK4 Protein in Oral Carcinogenesis
下载PDF
导出
摘要 目的:探讨CDK4蛋白在口腔粘膜癌变过程中表达的变化规律。方法:采用链菌素-生物素免疫组织化学染色法,对正常口腔粘膜、癌前损害、口腔鳞状细胞癌等共计80例标本中CDK4蛋白的表达进行检测,并与同批标本的P16蛋白的免疫组织化学染色结果进行相关性分析。结果:口腔粘膜癌前损害中出现CDK4蛋白的过表达,其阳性率及表达强度与P16蛋白的表达密切相关。结论:CDK4的过表达可能是口腔粘膜癌前损害发生发展中的增殖刺激因子,并可能引发P16的代偿作用。 Objective: To study the expression of cyclin dependant kinase 4(CDK4) protein in oral carcinogenesis. Methods: An LSAB immunohistochemistry method was applied to 80 cases of parrafin fixed tissues to study the expression and distribution of CDK4 in normal oral mucosa, oral premalignant leision (OPL) and oral squamous cell carcinoma. Results: The overexpression of CDK4 protein was observed in the progression of OPL. Meanwhile, a correlation analysis was appilied to investigate the relationship between P16 and CDK4 expression, and the result showed that the coeffient of correlation was 0.813, which was statistically significant. Conclusion: The overexpression of CDK4 is invovled in the progression of OPL, and there is a positive feedback loop between CDK4 and P16.
出处 《华西口腔医学杂志》 CAS CSCD 北大核心 1999年第1期8-10,I002,共4页 West China Journal of Stomatology
基金 国家自然科学基金 国家教委博士点基金
关键词 CDK4蛋白 口腔粘膜癌 癌前病变 CDK4 protein\ \ P16 protein\ \ oral premalignant lesion\ \ immunohistochemistry
  • 相关文献

参考文献3

共引文献5

同被引文献49

  • 1韦俊荣,任晓勇,郑国玺.IL-1α和MMP-9在中耳胆脂瘤上皮中的表达[J].西安交通大学学报(医学版),2005,26(5):495-497. 被引量:1
  • 2Eissa S, Ali-Labib R, Khalifa A. Deletions of p16 and p15 genes in schistosomiasis-associated bladder cancer (SABC)[J]. Clin Chim Acta, 2000, 300(1 -2): 159- 169.
  • 3Pande P, Soni S, Kaur J, et al. Prognostic factors in betel and tobacco related oral cancer[J]. Oral Oncol, 2002, 38(5): 491 - 499.
  • 4Shintani S, Mihara M, Nakahara Y, et al. Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity[J]. Oral Oncol, 2002. 38(3): 235 - 243.
  • 5Roesler JM, Livingston EH, Srivatsan E, et al. Deletion of p15 (MTS2) in the head and neck squamous cell carcinomas[J]. J Surg Res, 1998, 77(1): 50-54.
  • 6Zhou M, Gu L, Yeager AM, et al. Incidence and clinical significance of CDKN2/MTS1/pl6ink4A and MTS2/pl5ink4B gene deletions in childhood acute lymphoblastic leukemia[J]. Pediatr Hematol Oncol, 1997, 14(2): 141 - 150.
  • 7Geradts J, Kratzke RA, Niehans GA, et al. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product pl6INK4A in archival human solid tumors: correlation with retinoblastoma protein expression[J]. Cancer Res, 1995, 55 (24): 6006 - 6011.
  • 8Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types[J]. Science, 1994, 264(5157): 436-440.
  • 9Benedict WF, Lerner SP, Zhou J, et al. Level of retinoblastoma protein expression correlates with pl6(MTS-1/INK4A/CDKN2) status in bladder cancer[J]. Oncogene, 1999, 18(5): 1197 -1203.
  • 10Sartor M, Steingrimsdottir H, Elamin F, et al. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines[J]. Br J Cancer, 1999, 80(1 -2): 79 -86.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部